UT Health San Antonio becomes first civilian center in South Texas to launch FDA-approved radiotherapy treatment for advanced prostate cancer
October 6, 2023
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO, Oct. 6, 2023 – The University of Texas Health Science Center at San Antonio (UT Health San Antonio) announces the successful launch of Pluvicto, a radiopharmaceutical used to treat pa …
News-Medical.net: Newly identified protein markers could signal early development of metastatic lung cancer
October 6, 2023
The UT Health San Antonio Mays Cancer Center, along with Josephine Taverna, MD, Department of Medicine, Division of Hematology and Oncology, and Tim Hui-Ming Huang, PhD, chair, Department of Molecular Medicine, were mentioned in this article. R …
Bollyinside: Early Metastatic Lung Cancer Markers Identified: Potential Breakthrough in Treatment, says Mays Cancer Center Study
October 6, 2023
The UT Health San Antonio Mays Cancer Center, along with Josephine Taverna, MD, Department of Medicine, Division of Hematology and Oncology, and Tim Hui-Ming Huang, PhD, chair, Department of Molecular Medicine, were mentioned in this article. R …
Join the fun during Spirit Week Oct. 16–20! People. Power. Partnerships.
October 6, 2023
Thank you for powering UT Health San Antonio! You play an important role in fulfilling the promise we hold to make tomorrow a brighter, healthier day. Your partnership is what fuels our journey in advancing our missions and making a positive and …
New research led by Mays Cancer Center reveals how mutations in BRCA1 affect cancer susceptibility in women
October 6, 2023
Three decades after discoveries linking mutations in the BRCA1 gene to breast and ovarian cancer susceptibility, research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has pinpointed t …
New research led by Mays Cancer Center reveals how mutations in BRCA1 affect cancer susceptibility in women
October 6, 2023
Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO, Oct. 6, 2023 – Three decades after discoveries linking mutations in the BRCA1 gene to breast and ovarian cancer susceptibility, research led by Mays Cancer Center at The University of …
Leaders mark LEAP graduation
October 5, 2023
Sixteen faculty and staff leaders from across the institution recently completed the nine-month Leadership Excellence for Academic Professionals program. LEAP graduation on Sept. 22 was marked by the eight-member teams’ presentations to a panel of seni …
Mays Cancer Center: Targeting certain molecular interactions could yield new strategies for treating prostate cancer
October 5, 2023
Research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio has discovered that altering certain molecular interactions could yield new strategies for treating prostate cancer and related diseases. The study focus …
Mays Cancer Center: Targeting certain molecular interactions could yield new strategies for treating prostate cancer
October 5, 2023
Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO, Oct. 5, 2023 – Research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has discovered that altering certain molecula …
Mays Cancer Center at UT Health San Antonio identifies possible markers for early metastatic lung cancer
October 4, 2023
Researchers at Mays Cancer Center at The University of Texas Health Science at San Antonio have identified protein markers that could signal for early development of metastatic lung cancer, providing possibilities for new treatment. The findings alread …